RE:RE:RE:RE:RE:Where is everyone?Again, the 2 new OTC from biosyent will bring a potential of $20M in annual sales. Today, the stock went up by 11% or increased its market cap by about $10M, quite substantial. If sly you are correct, and one or two OTCs are commercialized with similar annual potential revenue, the stock could well climb to 0.50 if same reaction than biosyent (daily market cap increase of $10M). Just my two cents